The hazard
Platelet Reactivity Test distributed without appropriate US-FDA market clearance; if used healthcare personnel could use the baseline PRUTest measurement prior to initiating drug therapy, and then use the percent inhibition formula in the notice to manually calculate the percentage of platelet aggregation inhibition for a given patient receiving drug treatment with P2Y12 receptor inhibitor.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
VerifyNow P2Y12 Platelet Reactivity Test, REF: 85064
- Brand / company
- Accriva Diagnostics, Inc.
- Codes / lots
- UDI-DI: 10711234150054. Lot: WL1145. Expiration: 2025-10-18
- Distribution
- US Nationwide distribution in the state of VA.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 22 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.